Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
3.210
+0.160 (5.25%)
At close: Jun 6, 2025, 4:00 PM
3.295
+0.085 (2.65%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Annovis Bio Employees
As of December 31, 2024, Annovis Bio had 15 total employees, including 8 full-time and 7 part-time employees. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$1,937,366
Market Cap
62.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ANVS News
- 2 days ago - Annovis to Host Webinar and Live Q&A on June 24, 2025 - GlobeNewsWire
- 25 days ago - Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewsWire
- 2 months ago - Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewsWire
- 2 months ago - Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program - GlobeNewsWire
- 2 months ago - Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment - GlobeNewsWire
- 3 months ago - Annovis to Host Patients' Live Forum on February 27, 2025 - GlobeNewsWire